Electroencephalographic Cross-Frequency Coupling as a Sign of Disease Progression in Patients With Mild Cognitive

Christian Sandøe Musaeus1, Malene Schjønning Nielsen2, Jørgen Sandøe Musaeus3

  • 1Department of Neurology, Danish Dementia Research Centre (DDRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Insights

Patients with progressing Mild Cognitive Impairment (MCI) show lower gamma/theta cross-frequency coupling (CFC) compared to stable MCI. This brain oscillation pattern may indicate future Alzheimer's disease development.

Area of Science:

  • Neuroscience
  • Cognitive Science
  • Biomarkers

Background:

  • Mild Cognitive Impairment (MCI) is a precursor to Alzheimer's Disease (AD), but not all individuals with MCI progress.
  • Brain oscillations and their interactions, specifically cross-frequency coupling (CFC), are implicated in cognitive functions like memory.
  • Understanding changes in CFC may differentiate MCI patients who progress to AD from those who remain stable.

Purpose of the Study:

  • To investigate alterations in gamma/theta cross-frequency coupling (CFC) in patients with AD and MCI compared to healthy controls (HC).
  • To compare gamma/theta CFC between patients with progressing MCI (pMCI) and stable MCI (sMCI).
  • To explore the association between gamma/theta CFC and cognitive test scores.

Main Methods:

  • Electroencephalography (EEG) data were collected at baseline from 15 AD patients, 25 MCI patients, and 36 HC.
  • Participants were followed for up to 3 years.
  • Gamma/theta cross-frequency coupling (CFC) was quantified using the modulation index (MI).

Main Results:

  • Patients with pMCI exhibited significantly lower global gamma/theta CFC compared to patients with sMCI.
  • Global gamma/theta CFC showed a significant positive correlation with the Addenbrooke's Cognitive Examination (ACE) score.
  • While not statistically significant, AD and MCI patients displayed reduced gamma/theta CFC relative to HC.

Conclusions:

  • A decrease in gamma/theta CFC may serve as a potential progression marker for MCI towards AD.
  • Gamma/theta CFC is associated with cognitive performance, suggesting its importance in maintaining cognitive function.
  • Larger studies are required to validate gamma/theta CFC as a reliable progression marker in MCI.

Related Concept Videos